BioStem Technologies, Inc. BSEM
Set alert
1.23 USD +0.07 +5.60%
As of Nov 3, 11:25 AM ET
1.12 Day range 1.27
1.11 52-week range 8.40
- YTD
- -67.85%
- 1 year
- -72.03%
- Open
- 1.23
- Prev close
- 1.16
- Mkt cap
- 22.87M
- Vol
- 119.24K
- Avg vol
- 154.11K
- EPS
- 0.88
- P/E
- 1.39
- Div yield
- 0.00%
More statistics
- Low
- 1.12
- High
- 1.27
- Earnings
- Aug 12, 2024
6M chart
Signals (36)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
Newest 20 of 36.
Financial health
Altman Z-Score
-3.30 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -9.8×
FY 2016 5y median -6.9× FY 2025
P/S 1.3×
FY 2016 5y median 2.2× FY 2025
P/B 1.6×
FY 2016 5y median -1.6× FY 2025
P/FCF 9.7×
FY 2016 5y median -21.7× FY 2025
EV/EBITDA -122×
FY 2016 5y median -11.2× FY 2025
EV/Sales 0.8×
FY 2016 5y median 3.3× FY 2025
FCF Yield 10.3%
FY 2016 5y median -0.5% FY 2025
Profitability
Gross Margin 93.1%
FY 2016 5y median 92.4% FY 2025
Operating Margin -1.5%
FY 2016 5y median -37.0% FY 2025
Net Margin -13.9%
FY 2016 5y median -33.3% FY 2025
ROE -16.8%
FY 2016 5y median 78.0% FY 2025
ROIC -1.6%
FY 2016 5y median -1.6% FY 2025
ROA -13.2%
FY 2016 5y median -54.1% FY 2025
Growth (YoY)
Revenue -84.3%
FY 2016 FY 2025
Operating Income -102.2%
FY 2016 FY 2025
EPS (diluted) -126.5%
FY 2016 FY 2025
Free Cash Flow -72.6%
FY 2016 FY 2025
Financial Health
Current Ratio 4.1×
FY 2016 5y median 0.8× FY 2025
Quick Ratio 3.9×
FY 2016 5y median 0.8× FY 2025
Debt / Equity 0.1×
FY 2016 5y median -0.8× FY 2025
Net Debt / EBITDA 85.1×
FY 2016 5y median -0.6× FY 2025
Interest Coverage 0.0×
FY 2016 5y median -3.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
